Cochrane Abstracts
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Flumazenil Versus Placebo or No Intervention for People With Cirrhosis and Hepatic Encephalopathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435080/all/Flumazenil_versus_placebo_or_no_intervention_for_people_with_cirrhosis_and_hepatic_encephalopathy.
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435080/all/Flumazenil_versus_placebo_or_no_intervention_for_people_with_cirrhosis_and_hepatic_encephalopathy. Accessed December 6, 2024.
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435080/all/Flumazenil_versus_placebo_or_no_intervention_for_people_with_cirrhosis_and_hepatic_encephalopathy
Flumazenil Versus Placebo or No Intervention for People With Cirrhosis and Hepatic Encephalopathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435080/all/Flumazenil_versus_placebo_or_no_intervention_for_people_with_cirrhosis_and_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy
ID - 435080
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435080/all/Flumazenil_versus_placebo_or_no_intervention_for_people_with_cirrhosis_and_hepatic_encephalopathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
